- Home
- GPCR vs TFIN Comparison
GPCR vs TFIN Comparison
Compare GPCR & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- TFIN
- Stock Information
- Founded
- GPCR 2016
- TFIN 1981
- Country
- GPCR United States
- TFIN United States
- Employees
- GPCR N/A
- TFIN N/A
- Industry
- GPCR
- TFIN Major Banks
- Sector
- GPCR
- TFIN Finance
- Exchange
- GPCR Nasdaq
- TFIN Nasdaq
- Market Cap
- GPCR 1.1B
- TFIN 1.4B
- IPO Year
- GPCR 2023
- TFIN N/A
- Fundamental
- Price
- GPCR $21.13
- TFIN $58.80
- Analyst Decision
- GPCR Strong Buy
- TFIN Hold
- Analyst Count
- GPCR 8
- TFIN 6
- Target Price
- GPCR $79.29
- TFIN $68.50
- AVG Volume (30 Days)
- GPCR 726.2K
- TFIN 204.0K
- Earning Date
- GPCR 05-08-2025
- TFIN 07-16-2025
- Dividend Yield
- GPCR N/A
- TFIN N/A
- EPS Growth
- GPCR N/A
- TFIN N/A
- EPS
- GPCR N/A
- TFIN 0.37
- Revenue
- GPCR N/A
- TFIN $401,390,000.00
- Revenue This Year
- GPCR N/A
- TFIN $12.09
- Revenue Next Year
- GPCR N/A
- TFIN $14.37
- P/E Ratio
- GPCR N/A
- TFIN $153.03
- Revenue Growth
- GPCR N/A
- TFIN 0.68
- 52 Week Low
- GPCR $13.22
- TFIN $42.90
- 52 Week High
- GPCR $57.59
- TFIN $110.58
- Technical
- Relative Strength Index (RSI)
- GPCR 36.98
- TFIN 53.99
- Support Level
- GPCR $21.35
- TFIN $56.72
- Resistance Level
- GPCR $22.98
- TFIN $59.14
- Average True Range (ATR)
- GPCR 1.21
- TFIN 2.29
- MACD
- GPCR -0.43
- TFIN -0.26
- Stochastic Oscillator
- GPCR 2.71
- TFIN 62.81
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.